Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Relationship between Bone Marrow PD-1 and PD-L1 Expression and the Presence of Osteolytic Bone Disease in Multiple Myeloma Patients

Federica Costa, MS, Marina Bolzoni, PhD, Rosanna Vescovini, PhD, Fabrizio Accardi, MD, Anna Benedetta Dalla Palma, MD, Federica De Luca, PhD, Valentina Marchica, MS, Denise Toscani, PhD, Emanuela Vicario, MS, Paola Storti, PhD, Franco Aversa, MD, Nicola Giuliani, MD PhD

Blood (2018) 132 (Supplement 1): 3183.

https://doi.org/10.1182/blood-2018-99-118200

Published: 2018

Journal Articles

CD14 + CD16 + Monocyte Binding to Myeloma Cells Is Required for Daratumumab Dependent Killing in Multiple Myeloma Patients

Paola Storti, PhD, Rosanna Vescovini, PhD, Valentina Marchica, MS, Marina Bolzoni, PhD, Federica Costa, MS, Emanuela Vicario, MS, Denise Toscani, PhD, Anna Benedetta Dalla Palma, MD, Fabrizio Accardi, MD, Fabio Malavasi, MD, Franco Aversa, MD, Nicola Giuliani, MD PhD

Blood (2018) 132 (Supplement 1): 3200.

https://doi.org/10.1182/blood-2018-99-112873

Published: 2018

Journal Articles

Soluble CX3CL1/Fractalkine Is a New Player in the Pro-Inflammatory Microenvironment of Multiple Myeloma Patients Related to Bone Marrow Plasma Cell Infiltration and Neo-Vascularization

Anna Corcione, Valentina Marchica, Elisa Ferretti, Denise Toscani, PhD, Marina Bolzoni, PhD, Federica Costa, PhD, Cristina Mancini, MD, Eugenia Martella, MD, Fabrizio Accardi, MD, Laura Notarfranchi, MD, Domenico Ribatti, MD, Angelo Vacca, MD PhD, Franco Aversa, MD, Vito Pistoia, MD, Nicola Giuliani, MD PhD

Blood (2017) 130 (Supplement 1): 3044.

https://doi.org/10.1182/blood.V130.Suppl_1.3044.3044

Published: 2017

Journal Articles

Effect of Continuous Lenalidomide Treatment on Copy Number Alteration and Cytogenetic Abnormalities in Multiple Myeloma Cells

Paola Storti, PhD, Marina Bolzoni, PhD, Francesca Novara, PhD, Giannalisa Todaro, PhD, Valentina Marchica, Federica Costa, PhD, Tania Maldacena, PhD, Laura Notarfranchi, MD, Fabrizio Accardi, MD, Orsetta Zuffardi, PhD, Franco Aversa, MD, Nicola Giuliani, MD PhD, Gabriella Sammarelli, PhD

Blood (2017) 130 (Supplement 1): 3039.

https://doi.org/10.1182/blood.V130.Suppl_1.3039.3039

Published: 2017

Journal Articles

Lenalidomide Increases Human Dendritic Cell Maturation in Multiple Myeloma Modulating Both Monocyte Differentiation and Mesenchymal Stromal Cell Inhibitory Properties through Ikaros and Casein Kinase 1 Degradation, Respectively

Federica Costa, Marina Bolzoni, PhD, Rosanna Vescovini, PhD, Valentina Marchica, Fabrizio Accardi, MD, Laura Notarfranchi, MD, Benedetta Dalla Palma, MD, Cristina Manferdini, Gina Lisignoli, Sabrina Manni, PhD, Francesco Piazza, MD, Franco Aversa, MD, Nicola Giuliani, MD PhD

Blood (2016) 128 (22): 4464.

https://doi.org/10.1182/blood.V128.22.4464.4464

Published: 2016

Journal Articles

Oncolytic Virotherapy in Multiple Myeloma: A Possible Alternative Role of Bovine Viruses.

Valentina Marchica, Gaetano Donofrio, PhD, Rosanna Vescovini, PhD, Giulia Tebaldi, Alfonso Rosamilia, Daniela Guasco, Paola Storti, PhD, Marina Bolzoni, PhD, Federica Costa, Chiara Schifano, MSc, Sabrina Bonomini, MSc, Fabrizio Accardi, MD, Francesco Piazza, MD, Franco Aversa, MD, Nicola Giuliani, MD PhD

Blood (2016) 128 (22): 2093.

https://doi.org/10.1182/blood.V128.22.2093.2093

Published: 2016

Journal Articles

Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target

Blood (2016) 128 (5): 667–679.

https://doi.org/10.1182/blood-2016-01-690743

Published: 2016

Includes: Supplemental data

Journal Articles

The Myeloma Cells Escape from Bone Marrow to Skin Extramedullary Localization upon Bortezomib Resistance: Role of CXCR4

Valentina Marchica, Fabrizio Accardi, MD, Paola Storti, PhD, Cristina Mancini, MD, Eugenia Martella, MD, Marina Bolzoni, PhD, Katia Todoerti, Chiara Schifano, Sabrina Bonomini, Benedetta Dalla Palma, MD, Magda Marcatti, MD, Maurilio Ponzoni, MD, Antonino Neri, MD, Franco Aversa, MD, Nicola Giuliani, MD PhD

Blood (2015) 126 (23): 5315.

https://doi.org/10.1182/blood.V126.23.5315.5315

Published: 2015

Journal Articles

Generation and Characterization of Microvesicles after Daratumumab Interaction with Myeloma Cells

Antonella Chillemi, PhD, Valeria Quarona, Andrea Zito, Fabio Morandi, PhD, Danilo Marimpietri, Massimiliano Cuccioloni, PhD, Oldham J Robert, Cragg S Mark, PhD, Marina Bolzoni, PhD, Denise Toscani, PhD, Vito Pistoia, MD, Nicola Giuliani, MD PhD, Alberto L Horenstein, PhD, Kate Sasser, PhD, Fabio Malavasi, MD

Blood (2015) 126 (23): 1849.

https://doi.org/10.1182/blood.V126.23.1849.1849

Published: 2015

Journal Articles

Hypoxia-Inducible Factor (HIF)-1alpha Inhibitionin Myeloma Cells Significantly Increases the Anti-Myeloma Effect of Lenalidomide in Vivo

Paola Storti, PhD, Valentina Marchica, Denise Toscani, PhD, Irma Airoldi, PhD, Sophie Maiga, PhD, Marina Bolzoni, PhD, Nicoletta Campanini, Eugenia Martella, MD, Cristina Mancini, MD, Valentina Ferri, Gaetano Donofrio, PhD, Martine Amiot, PhD, Franco Aversa, MD, Nicola Giuliani, MD PhD

Blood (2015) 126 (23): 3012.

https://doi.org/10.1182/blood.V126.23.3012.3012

Published: 2015

Journal Articles

Expression Profile of CD38 and Related Ectoenzymes in Myeloma Bone Niche: A Rational Basis for the Use of Daratumumab to Inhibit Osteoclast Formation and Activity

Denise Toscani, PhD, Marina Bolzoni, PhD, Federica Costa, Valeria Quarona, Valentina Marchica, Cristina Mancini, MD, Eugenia Martella, MD, Sabrina Bonomini, Paola Storti, PhD, Antonella Chillemi, PhD, Fabrizio Accardi, MD, Benedetta Dalla Palma, MD, Luisa Craviotto, MD, Fabio Malavasi, MD, Franco Aversa, MD, Nicola Giuliani, MD PhD

Blood (2015) 126 (23): 2959.

https://doi.org/10.1182/blood.V126.23.2959.2959

Published: 2015

Journal Articles

Ectoenzymes and Their Products As Communicators in the Human Myeloma Niche

Alberto L. Horenstein, PhD, Valentina Ferri, Marina Bolzoni, Valeria Quarona, Antonella Chillemi, Gianluca Zaccarello, Nicola Giuliani, MD PhD, Fabio Malavasi, MD PhD

Blood (2014) 124 (21): 2064.

https://doi.org/10.1182/blood.V124.21.2064.2064

Published: 2014

Journal Articles

Ammonium Production and Glutamine-Addiction of Myeloma Cells: New Attractive Targets in Multiple Myeloma

Fabrizio Accardi, MD, Martina Chiu, Marina Bolzoni, Paola Storti, PhD, Katia Todoerti, PhD, Luca Agnelli, Massimiliano Ferrari, MD, Gabriele Missale, MD, Franco Aversa, MD, Ovidio Bussolati, MD PhD, Nicola Giuliani, MD PhD

Blood (2014) 124 (21): 2067.

https://doi.org/10.1182/blood.V124.21.2067.2067

Published: 2014

Journal Articles

Galectin-1 Is Highly Expressed By Myeloma Cells and the Bone Marrow Microenvironment and Its Suppression Delineates a New Therapeutic in Vitro and in Vivo Strategy in Multiple Myeloma

Paola Storti, PhD, Gaetano Donofrio, PhD, Valentina Marchica, Daniela Guasco, Katia Todoerti, PhD, Irma Airoldi, PhD, Judith Anderson, Marina Bolzoni, Valentina Ferri, Eugenia Martella, MD, Cristina Mancini, MD, Nicoletta Campanini, Antonino Neri, G. David Roodman, MD, PhD, Franco Aversa, MD, Nicola Giuliani, MD PhD

Blood (2014) 124 (21): 3373.

https://doi.org/10.1182/blood.V124.21.3373.3373

Published: 2014

Journal Articles

Overexpression of Pro-Osteoclastogenic Cytokine Receptors and Chemokines By Bone Marrow CD14 + Monocytes of Multiple Myeloma (MM) Patients As Compared to Smoldering MM (SMM) and Monoclonal Gammopathy of Uncertain Significance (MGUS): Role of Interleukin(IL)-21 Receptor/IL-21 Axis in MM-Induced Osteoclastogenesis

Marina Bolzoni, Domenica Ronchetti, Paola Storti, PhD, Daniela Guasco, Valentina Marchica, Luca Agnelli, PhD, Benedetta Dalla Palma, MD, Fabrizio Accardi, MD, Federica Costa, Denise Toscani, Sabrina Bonomini, Benjamin Thomas, PhD, Antonino Neri, Franco Aversa, MD, Nicola Giuliani, MD PhD

Blood (2014) 124 (21): 28.

https://doi.org/10.1182/blood.V124.21.28.28

Published: 2014

Journal Articles

Relationship Between Presence Of Osteolytic Lesions, Cytogenetic Features and Bone Marrow Levels Of Cytokines and Chemokines In Multiple Myeloma Patients: Role Of Chemokine (C-C motif) Ligand 20

Nicola Giuliani, MD, PhD, Benedetta Dalla Palma, MD, Daniela Guasco, Mario Pedrazzoni, MD, PhD, Marina Bolzoni, Gabriella Sammarelli, PhD, Paola Storti, PhD, Angelica Spolzino, MD, Luisa Craviotto, MD, Massimo De Filippo, MD, Livia Ruffini, MD, Franco Aversa, MD

Blood (2013) 122 (21): 3110.

https://doi.org/10.1182/blood.V122.21.3110.3110

Published: 2013

Journal Articles

Myeloma-Induced Osteocyte Death Was Blunted By Proteasome Inhibitors Through The Modulation Of Autophagy

Denise Toscani, Carla Palumbo, MD, Benedetta Dalla Palma, MD, Marina Bolzoni, Marzia Ferretti, Paola Sena, Daniela Guasco, Eugenia Martella, MD, Franco Aversa, MD, Nicola Giuliani, MD, PhD

Blood (2013) 122 (21): 3096.

https://doi.org/10.1182/blood.V122.21.3096.3096

Published: 2013

Journal Articles

IL3 Induces Osteoclastogenesis In Vivo and Is Modulated By Bone Marrow Monocyte / Macrophage Derived Activin A

Rebecca Silbermann, MD, Marina Bolzoni, Paola Storti, PhD, Daniela Guasco, Judith Anderson, Jolene J. Windle, PhD, G. David Roodman, MD, PhD, Nicola Giuliani, MD, PhD

Blood (2013) 122 (21): 3101.

https://doi.org/10.1182/blood.V122.21.3101.3101

Published: 2013

Journal Articles

Trascriptome Analysis of Bone Marrow CD14 + Monocytes Revealed Differential Expression Profiles in Symptomatic Multiple Myeloma (MM) Compared to Smoldering MM and Monoclonal Gammopathy of Undetermined Significance

Marco Peronaci, Paola Storti, PhD, Domenica Ronchetti, Luca Agnelli, PhD, Marina Bolzoni, Daniela Guasco, Denise Toscani, Benedetta Dalla Palma, MD, Sabrina Bonomini, Gabriella Sammarelli, PhD, Luisa Craviotto, MD, Antonino Neri, Franco Aversa, MD, Nicola Giuliani

Blood (2012) 120 (21): 1811.

https://doi.org/10.1182/blood.V120.21.1811.1811

Published: 2012

Journal Articles

Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients

Denise Toscani, Benedetta Dalla Palma, MD, Carla Palumbo, Marzia Ferretti, Marina Bolzoni, Daniela Guasco, Cristina Mancini, MD, Eugenia Martella, MD, Mirca Lazzaretti, PhD, Mario Pedrazzoni, MD, PhD, Franco Aversa, MD, Nicola Giuliani

Blood (2012) 120 (21): 3978.

https://doi.org/10.1182/blood.V120.21.3978.3978

Published: 2012

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Relationship between Bone Marrow PD-1 and PD-L1 Expression and the Presence of Osteolytic Bone Disease in Multiple Myeloma Patients

CD14 + CD16 + Monocyte Binding to Myeloma Cells Is Required for Daratumumab Dependent Killing in Multiple Myeloma Patients

Soluble CX3CL1/Fractalkine Is a New Player in the Pro-Inflammatory Microenvironment of Multiple Myeloma Patients Related to Bone Marrow Plasma Cell Infiltration and Neo-Vascularization

Effect of Continuous Lenalidomide Treatment on Copy Number Alteration and Cytogenetic Abnormalities in Multiple Myeloma Cells

Lenalidomide Increases Human Dendritic Cell Maturation in Multiple Myeloma Modulating Both Monocyte Differentiation and Mesenchymal Stromal Cell Inhibitory Properties through Ikaros and Casein Kinase 1 Degradation, Respectively

Oncolytic Virotherapy in Multiple Myeloma: A Possible Alternative Role of Bovine Viruses.

Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target

The Myeloma Cells Escape from Bone Marrow to Skin Extramedullary Localization upon Bortezomib Resistance: Role of CXCR4

Generation and Characterization of Microvesicles after Daratumumab Interaction with Myeloma Cells

Hypoxia-Inducible Factor (HIF)-1alpha Inhibitionin Myeloma Cells Significantly Increases the Anti-Myeloma Effect of Lenalidomide in Vivo

Expression Profile of CD38 and Related Ectoenzymes in Myeloma Bone Niche: A Rational Basis for the Use of Daratumumab to Inhibit Osteoclast Formation and Activity

Ectoenzymes and Their Products As Communicators in the Human Myeloma Niche

Ammonium Production and Glutamine-Addiction of Myeloma Cells: New Attractive Targets in Multiple Myeloma

Galectin-1 Is Highly Expressed By Myeloma Cells and the Bone Marrow Microenvironment and Its Suppression Delineates a New Therapeutic in Vitro and in Vivo Strategy in Multiple Myeloma

Relationship Between Presence Of Osteolytic Lesions, Cytogenetic Features and Bone Marrow Levels Of Cytokines and Chemokines In Multiple Myeloma Patients: Role Of Chemokine (C-C motif) Ligand 20

Myeloma-Induced Osteocyte Death Was Blunted By Proteasome Inhibitors Through The Modulation Of Autophagy

IL3 Induces Osteoclastogenesis In Vivo and Is Modulated By Bone Marrow Monocyte / Macrophage Derived Activin A

Trascriptome Analysis of Bone Marrow CD14 + Monocytes Revealed Differential Expression Profiles in Symptomatic Multiple Myeloma (MM) Compared to Smoldering MM and Monoclonal Gammopathy of Undetermined Significance

Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only